Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 719 | |||||||||
| Operating revenue | ---- | --719 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cost of revenue | ||||||||||
| Gross profit | 719 | |||||||||
| Operating expense | 159.65%4.76M | 1.84M | ||||||||
| Selling and administrative expenses | 34.94%1.57M | --1.17M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -General and administrative expense | 34.94%1.57M | --1.17M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Research and development costs | 1,130.74%2.59M | --210.71K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation amortization depletion | 600.99%4.96K | --708 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Depreciation and amortization | 600.99%4.96K | --708 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other operating expenses | 29.63%594.03K | --458.25K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | -159.75%-4.76M | -1.83M | ||||||||
| Net non-operating interest income (expenses) | 99.14%-2.34K | 6.55%-271.19K | -299.42%-290.2K | 3.18%-72.66K | 72.36%-75.04K | 32.60%-271.47K | -1,457.50%-402.8K | -59.45%-25.86K | 18.49%-16.22K | 64.11%-19.9K |
| Non-operating interest income | 652,640.00%32.64K | --5 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -87.10%34.98K | -6.55%271.2K | 299.42%290.2K | -3.18%72.66K | -72.36%75.04K | -32.60%271.47K | 1,457.50%402.8K | 59.45%25.86K | -18.49%16.22K | -64.11%19.9K |
| Other net income (expenses) | 714.62%923K | -150.18K | -2.64%-40.9K | -337.58%-39.85K | -9.11K | |||||
| Other non-operating income (expenses) | 714.62%923K | ---150.18K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -70.42%-3.84M | 33.20%-2.26M | 21.65%-3.38M | -300.17%-4.31M | 301.40%2.15M | 82.26%-1.07M | -16.20%-6.02M | -258.52%-5.18M | 191.51%3.27M | 45.90%-3.57M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -70.42%-3.84M | 33.20%-2.26M | 21.65%-3.38M | -300.17%-4.31M | 301.40%2.15M | 82.26%-1.07M | -16.20%-6.02M | -258.52%-5.18M | 191.51%3.27M | 45.90%-3.57M |
| Net income continuous operations | -70.42%-3.84M | 33.20%-2.26M | 21.65%-3.38M | -300.17%-4.31M | 301.40%2.15M | 82.26%-1.07M | -16.20%-6.02M | -258.52%-5.18M | 191.51%3.27M | 45.90%-3.57M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -70.42%-3.84M | 33.20%-2.26M | 21.65%-3.38M | -300.17%-4.31M | 301.40%2.15M | 82.26%-1.07M | -16.20%-6.02M | -258.52%-5.18M | 191.51%3.27M | 45.90%-3.57M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -70.42%-3.84M | 33.20%-2.26M | 21.65%-3.38M | -300.17%-4.31M | 301.40%2.15M | 82.26%-1.07M | -16.20%-6.02M | -258.52%-5.18M | 191.51%3.27M | 45.90%-3.57M |
| Diluted earnings per share | 61.06%-0.2103 | 50.91%-0.54 | 21.43%-1.1 | -300.00%-1.4 | 275.00%0.7 | 85.89%-0.4 | -16.00%-2.8346 | -256.25%-2.4436 | 194.12%1.5639 | 47.37%-1.6617 |
| Basic earnings per share | 61.06%-0.2103 | 50.91%-0.54 | 21.43%-1.1 | -300.00%-1.4 | 275.00%0.7 | 85.89%-0.4 | -16.00%-2.8346 | -256.25%-2.4436 | 194.12%1.5639 | 47.37%-1.6617 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |